:: Volume 13, Issue 2 (June 2021 2021) ::
IJBC 2021, 13(2): 62-64 Back to browse issues page
Triple Drug Iron Chelation Therapy in Thalassemia Major; A Case Report
Ramitha R Bhat, Harshaprasada Lashkari *, Stalin Ramprakash, Diana Pereira
Department of Pediatrics, Kasturba Medical College and Manipal Academy of Higher education (MAHE), Mangaluru, India
Abstract:   (355 Views)
Regular packed cell transfusion in patients with thalassemia major leads to iron overload. Chelation therapy is one of the important aspects of thalassemia care as iron overload causes significant cardiac, hepatic, and endocrine dysfunction. We report a case of thalassemia major with severe iron overload causing cardiac and liver dysfunction who benefitted from triple drug chelation therapy. Triple iron chelation therapy in thalassemia major could be suggested in severe iron overload patients.
Keywords: Thalassemia major, Iron overload, Chelation therapy, Monotherapy, Triple iron chelation therapy
Full-Text [PDF 396 kb]   (110 Downloads)    
: case report | Subject: Pediatric Hematology & Oncology
Received: 2020/05/9 | Accepted: 2021/06/9 | Published: 2021/07/15

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 2 (June 2021 2021) Back to browse issues page